Ignite Creation Date:
2024-05-05 @ 9:42 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00000742
Status:
COMPLETED
Last Update Posted:
2021-11-04
First Post:
1999-11-02
Brief Title:
A Phase I Concentration-Controlled Trial to Assess the Safety Tolerance Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate U-87201E Zidovudine AZT and Didanosine ddI
Sponsor:
Organization:
National Institute of Allergy and Infectious Diseases NIAID